Autoimmune Bullous Diseases in the Elderly
Literature Review
DOI:
https://doi.org/10.55175/cdk.v52i11.1572Keywords:
Autoimmune, elderly, bullous pemphigoid, pemphigus vulgaris, bullous diseaseAbstract
The increase in cases of bullous diseases in the elderly is related to various factors. Aging causes a decline in skin structure and integrity, making it more susceptible to bullous diseases. This disease occurs because the aging process causes immune system dysregulation, which increases the risk of autoimmune conditions. Bullous diseases that commonly occur in the elderly are usually bullous pemphigoid (an autoimmune bullous condition) and pemphigus vulgaris (a skin disease that causes blisters), which are associated with significant morbidity and mortality. Bullous pemphigoid is characterized by tense subepidermal blisters, while pemphigus vulgaris is characterized by loose suprabasal blisters that rupture easily. Histopathological examination and direct immunofluorescence are the gold standard for diagnosis. The management of autoimmune bullous diseases in the elderly is generally the same as for bullous diseases in general, such as corticosteroids and immunosuppressive agents. However, appropriate and effective management is necessary, along with increased attention to the risks of polypharmacy and drug side effects that may cause new problems in elderly patients, including an increased risk of infection, osteoporosis, and metabolic complications.
Downloads
References
Mutasim DF. Differential diagnosis of autoimmune bullous diseases in the elderly. Diagnosis of aging skin diseases [Internet]. New Jersey: Springer; 2008 [cited 2024 Sep 12];107–21. Available from: https://link.springer.com/chapter/10.1007/978-1-84628-678-0_10.
Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol.2014;28:1133–40. doi: 10.1111/jdv.12366.
Deotto M, Spiller A, Sernicola A, Alaibac M. Bullous pemphigoid: an immune disorder related to aging (review). Exp Ther Med.2021;23(1):50. doi: 10.3892/etm.2021.10972.
Patel F, Wilken R, Patel FB, Sultani H, Bustos I, Duong C, et al. Pathophysiology of autoimmune bullous diseases: Nature versus nurture. Indian J Dermatol. 2017;62(3):262–7. doi: 0.4103/0019-5154.159620.
Mutasim DF. Autoimmune bullous dermatoses in the elderly. In: Herdson C, editor. Drugs aging [Internet]. New Jersey: Springer;2003;20(9):663–81. Available from: https://link.springer.com/article/10.2165/00002512-200320090-00004.
Parker SRS, MacKelfresh J. Autoimmune blistering diseases in the elderly. Clin Dermatol. 2011;29(1):69–79. doi: 10.1016/j.clindermatol.2010.07.010.
Popescu IA, Vata D, Temelie Olinici D, Tarcau BM, Patrascu AI, Halip IA, et al. Epidemiological study of autoimmune bullous dermatoses in Northeastern Romania. Diagnostics. 2024;14(1):57. https://doi.org/10.3390/diagnostics14010057.
Onalaja-Underwood AA, Hurley MY, Sokumbi O. Diagnosis and management of bullous disease. Clin Geriatr Med. 2024 Feb;40(1):37–74. doi: 10.1016/j.cger.2023.09.002.
Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al. Fitzpatrick dermatology in general medicine. In: Payn AS, Stanley JR, editors. Pemphigus. 9th ed. New York: McGraw Hill; 2019. p. 909–25.
Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet 2019;394(10201):882–94. https://doi.org/10.1016/S0140-6736(19)31778-7.
Costan VV, Popa C, Hancu M, Porumb‑Andrese E, Toader M. Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (review). Exp Ther Med. 2021;22(5):1335. doi: 10.3892/etm.2021.10770.
Tarakji B. Pemphigus vulgaris in old patient. Case Rep Dent. 2021;2021:3. doi: 10.1155/2021/3946161
Payne AS, Stanley JR. Pemphigus. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick’s dermatology. 9th ed. NewYork: McGraw-Hill; 2019. p. 919–23.
Culton DA, Liu Z, Dias LA. Bullous pemphigoid. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick’s dermatology. 9th ed. NewYork: McGraw-Hill Ed; 2019. p. 948–51.
Rudnicka E, Napierała P, Podfigurna A, Męczekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas 2020 Sep:139:6–11. doi: 10.1016/j.maturitas.2020.05.018.
Singh S, Bajorek B. Defining “elderly” in clinical practice guidelines for pharmacotherapy. Pharm Pract (Granada). 2014 Mar 15;12(4):489. doi: 10.4321/s1886-36552014000400007.
Mutasim DF. Autoimmune bullous dermatoses in the elderly: diagnosis and management. Drugs Aging. 2003;20(9):663–81. doi: 10.2165/00002512-200320090-00004.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 dr. Gilang Widratama Putra, dr. Putu Dyah Ayu Saraswati, M.Sc, Sp.DVE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
